| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 03/16/2011 | EP2066643B1 Pyridazin-4-ylmethyl-sulfonamides used as fungicides and against arthropods |
| 03/16/2011 | EP1703906B1 Immuno inhibitory pyrazolone compounds |
| 03/16/2011 | EP1699761B1 Cb1 modulator compounds |
| 03/16/2011 | EP1344777B1 Imidazole derivatives, process for their preparation and their use |
| 03/15/2011 | US7906658 Antidiabetic agents |
| 03/15/2011 | US7906657 1,5-diphenylpyrazoles II as HSP90 inhibitors |
| 03/15/2011 | US7906655 5,5'-(1,2-ethynediyl)bis(2-((2S)-1-((2R)-2-phenylpropanoyl)-2-pyrrolidinyl)-1H-benzimidazole); inhibit the function of the NS5A protein encoded by Hepatitis C virus (HCV); useful in establishing or determining the binding site of other antiviral compounds |
| 03/15/2011 | US7906649 Aminocyclohexanes as dipeptidyl peptidase-IV inhibitors for the treatment of diabetes |
| 03/15/2011 | US7906646 Spirocyclic heterocyclic derivatives and methods of their use |
| 03/15/2011 | US7906644 2,4-pyrimidinediamine compounds and their uses |
| 03/15/2011 | US7906629 Protease inhibitor conjugates and antibodies useful in immunoassay |
| 03/15/2011 | US7906550 Viricide against hepatitis virus; pyrrole derivatives as, for example, 3-acetyl-4,5-dimethyl-2-pyrrole carboxylic acid |
| 03/15/2011 | US7906546 Tetrahydrocarbazoles and derivatives |
| 03/15/2011 | US7906545 Prodrugs of CC-1065 analogs |
| 03/15/2011 | US7906523 retrovirus inhibor; anticarcinogenic, antidiabetic agent, immunosuppressant, autoimmune diseases; 2-{6-[3(R)-Amino-piperidin-1-yl]-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl}-4-fluoro-benzonitrile; type 2 diabetes mellitus, impaired glucose tolerance, obesity, multiple sclerosis |
| 03/15/2011 | US7906513 Prevent reproduction; breaking life cycle;viricides |
| 03/15/2011 | US7906512 3,6-substituted imidazol[1,2-b]pyridazine analogs for treating allergic and inflammatory diseases |
| 03/15/2011 | US7906505 Apoptosis promoters |
| 03/15/2011 | US7906503 Substituted 3-alkyl and 3-alkenyl azetidine derivatives |
| 03/15/2011 | US7906501 Pyrrole derivatives with angiotensin II antagonist activity |
| 03/15/2011 | CA2630665C Heterocyclic compound having inhibitory activity on 11-.beta.-hydroxysteroid dehydrogenase type i |
| 03/15/2011 | CA2550596C 3-cycloalkylaminopyrrolidine derivatives as modulators of chemokine receptors |
| 03/15/2011 | CA2477774C Indolylmaleimide derivatives |
| 03/15/2011 | CA2432000C Pyrimidineamines as angiogenesis modulators |
| 03/15/2011 | CA2431160C Anilinopyrimidine derivatives as ikk inhibitors and compositions and methods related thereto |
| 03/15/2011 | CA2426440C Quinazoline derivatives as kinase inhibitors |
| 03/15/2011 | CA2394809C Benzazole derivatives and their use as jnk modulators |
| 03/15/2011 | CA2315117C Heterocyclic ether and thioether compounds useful in controlling chemical synaptic transmission |
| 03/10/2011 | WO2011028947A2 Heterocyclic compounds for the inhibition of pask |
| 03/10/2011 | WO2011028927A1 Selective sphingosine-1-phosphate receptor antagonists |
| 03/10/2011 | WO2011028741A1 Quinazolines as potassium ion channel inhibitors |
| 03/10/2011 | WO2011028507A2 Compositions, methods, and kits for determining an alkyl transferase |
| 03/10/2011 | WO2011028135A1 Kinase inhibitors, prodrug forms thereof and their use in therapy |
| 03/10/2011 | WO2011028044A2 Pyrazole derivatives, preparation method thereof, and composition for prevention and treatment of osteoporosis containing same |
| 03/10/2011 | WO2011028043A2 Pyrazole derivatives, preparation method thereof, and composition for prevention and treatment of osteoporosis containing same |
| 03/10/2011 | WO2011027940A1 Paramagnetic polynuclear metal complex having high self-relaxation rate, preparation method thereof, and contrast medium containing same |
| 03/10/2011 | WO2011027249A2 Benzimidazole derivatives |
| 03/10/2011 | WO2011026920A1 Bis-benzimidazole derivatives |
| 03/10/2011 | WO2011026835A1 Novel pyrimidine and triazine hepcidine antagonists |
| 03/10/2011 | WO2011026579A1 Substituted aminoquinoxalines as tyrosine threonine kinase inhibitors |
| 03/10/2011 | WO2011026241A1 Substituted heterocyclic derivatives for the treatment of pain and epilepsy |
| 03/10/2011 | WO2010118367A3 Antiviral pyrimidines |
| 03/10/2011 | WO2010093727A8 Quinazolinones as prolyl hydroxylase inhibitors |
| 03/10/2011 | US20110060142 Novel compositions and processes for preparing 5-amino or substituted amino 1,2,3-triazoles and triazole orotate formulations |
| 03/10/2011 | US20110060141 Regioselective preparation of substituted pyrimidines |
| 03/10/2011 | US20110060009 Hydroxamate-Based Inhibitors of Deacetylases |
| 03/10/2011 | US20110060006 Functionally Selective Alpha2C Adrenoreceptor Agonists |
| 03/10/2011 | US20110059996 Novel pyrrolo [3, 2-d] pyrimidin-4-one derivatives and their use in therapy |
| 03/10/2011 | US20110059992 New Compounds |
| 03/10/2011 | US20110059989 3,5-diamino-6-chloro-pyrazine-2-carboxylic acid derivatives and their use as epithelial sodium channel blockers for the treatment of airway diseases |
| 03/10/2011 | US20110059988 Isoxazoline compositions and their use as antiparasitics |
| 03/10/2011 | US20110059979 Piperidine/Cyclohexane Carboxamide Derivatives For Use as Vanilloid Receptor Modulators |
| 03/10/2011 | US20110059974 Novel retinamide retinoic acid metabolism blocking agents |
| 03/10/2011 | US20110059970 4-phenyl-1,3-thiazoles and 4-phenyl-1,3-oxazoles derivatives as cannabinoid receptor ligands |
| 03/10/2011 | US20110059969 Piperazines as anti-obesity agents |
| 03/10/2011 | US20110059966 Indole derivatives as histamine 3 receptor inhibitors for the treatment of cognitive and sleep disorders, obesity and other cns disorders |
| 03/10/2011 | US20110059964 Pyrazole derivatives and use thereof as orexin receptor antagonists |
| 03/10/2011 | US20110059962 Transcription factor modulating compounds and methods of use thereof |
| 03/10/2011 | US20110059959 Novel multicyclic compounds and the use thereof |
| 03/10/2011 | US20110059955 Novel 3-aminoalkyl-1,3-dihydro-2h-indol-2-one derivatives, preparation thereof and therapeutic use thereof |
| 03/10/2011 | US20110059942 Azetidinyl G-Protein Coupled Receptor Agonists |
| 03/10/2011 | US20110059939 Therapeutic compounds |
| 03/10/2011 | US20110059938 New chemical compounds |
| 03/10/2011 | US20110059935 Beta-LACTAMYL VASOPRESSIN V1a ANTAGONISTS |
| 03/10/2011 | US20110059161 Targeted delivery using tissue-specific peptidomimetic ligands |
| 03/10/2011 | US20110059154 Ccr5 antagonists as prophylactics for preventing hiv infection and methods of inhibiting transmission of same |
| 03/10/2011 | US20110059018 Covalently binding imaging probes |
| 03/10/2011 | CA2772790A1 Substituted aminoquinoxalines as tyrosine threonine kinase inhibitors |
| 03/10/2011 | CA2772714A1 Heterocyclic compounds for the inhibition of pask |
| 03/10/2011 | CA2772642A1 Quinazolines as potassium ion channel inhibitors |
| 03/10/2011 | CA2772484A1 Bis-benzimidazole derivatives |
| 03/10/2011 | CA2772194A1 Benzimidazole derivatives |
| 03/10/2011 | CA2771592A1 Substituted heterocyclic derivatives for the treatment of pain and epilepsy |
| 03/10/2011 | CA2771016A1 Kinase inhibitors, prodrug forms thereof and their use in therapy |
| 03/09/2011 | EP2292615A1 Quinazoline compounds |
| 03/09/2011 | EP2292614A1 Substituted pyrimidines as aurora kinase inhibitors |
| 03/09/2011 | EP2292613A1 Dihydroindolinone derivatives |
| 03/09/2011 | EP2292604A2 Condensed-cyclic compound and organic light emitting diode having organic layer including the same |
| 03/09/2011 | EP2292601A1 Phenanthro[2,3-b]pyrroles and Phenanthro[3,2-b]pyrroles for organic light-emitting devices |
| 03/09/2011 | EP2292228A1 Pyrazole derivatives as 11-beta-HSD1 inhibitors |
| 03/09/2011 | EP2292227A2 Pyrazole derivatives modulators of hepatocyte growth factor (scatter factor) activity |
| 03/09/2011 | EP2291366A2 Preparation of imatinib mesylate |
| 03/09/2011 | EP2291359A1 Phenyl or pyridinyl substituted indazoles derivatives |
| 03/09/2011 | EP2291076A1 Angiotensin ii receptor antagonists |
| 03/09/2011 | EP2077998B1 Phthalazine, aza- and diaza-phthalazine compounds and methods of use |
| 03/09/2011 | EP1874770B1 Phenylacetamides suitable as protein kinase inhibitors |
| 03/09/2011 | EP1841735B1 Indoles useful in the treatment of inflammation |
| 03/09/2011 | EP1692116B1 1,2,3-triazole amide derivatives as inhibitors of cytokine production |
| 03/09/2011 | EP1620434B1 Fused bicyclic-substituted amines as histamine-3 receptor ligands |
| 03/09/2011 | EP1569910B1 Pesticidal sulphonylaminopyrazoles |
| 03/09/2011 | EP1513812B1 Substituted indoles |
| 03/09/2011 | EP1497279B1 Substituted indoles and their use as 5ht-reuptake inhibitors and as 5ht ligands |
| 03/09/2011 | EP1491206B9 Use of peptide derivatives for inducing cell differentiation |
| 03/09/2011 | CN1582274B Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade |
| 03/09/2011 | CN101326167B Pyridiazinone derivatives for tumour treatment |
| 03/09/2011 | CN101230033B New azabicycloalkane derivatives, preparing method and medicament combination containing the same |
| 03/08/2011 | US7902369 Diaryl-substituted five-membered heterocycle derivative |
| 03/08/2011 | US7902366 NK1 antagonists |
| 03/08/2011 | US7902361 Pyrimidin-4-yl-3, 4-thione compounds and their use in therapy |
| 03/08/2011 | US7902358 Gastrointestinal disorders; inflammatory bowel disorders; gastroesophageal reflux, constipation; diarrhea |